NEPHROGENEX INC's ticker is NRXGQ and the CUSIP is 640667101. A total of 14 filers reported holding NEPHROGENEX INC in Q2 2015. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2016 | $0 | -100.0% | 813 | 0.0% | 0.00% | – |
| Q4 2015 | $1,000 | -66.7% | 813 | 0.0% | 0.00% | – |
| Q3 2015 | $3,000 | -25.0% | 813 | +21.2% | 0.00% | – |
| Q2 2015 | $4,000 | 0.0% | 671 | +18.1% | 0.00% | – |
| Q1 2015 | $4,000 | -50.0% | 568 | 0.0% | 0.00% | – |
| Q4 2014 | $8,000 | +166.7% | 568 | 0.0% | 0.00% | – |
| Q3 2014 | $3,000 | 0.0% | 568 | 0.0% | 0.00% | – |
| Q2 2014 | $3,000 | – | 568 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RHO CAPITAL PARTNERS INC | 1,326,826 | $17,713,000 | 7.86% |
| LMR Partners LLP | 124,710 | $1,665,000 | 0.22% |
| Visium Asset Management, LP | 658,969 | $8,798,000 | 0.12% |
| FIRST NEW YORK SECURITIES LLC /NY | 1,000 | $13,350,000 | 0.02% |
| Knoll Capital Management, LLC | 3,072 | $41,000 | 0.02% |
| Edge Wealth Management LLC | 500 | $7,000 | 0.00% |
| MORGAN STANLEY | 186,015 | $2,483,000 | 0.00% |
| UBS Group AG | 2,699 | $36,000 | 0.00% |
| BANK OF AMERICA CORP /DE/ | 9,100 | $121,000 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 10,000 | $133,000 | 0.00% |